{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:44:46Z","timestamp":1775321086688,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jviromet.2023.114858","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T22:38:15Z","timestamp":1701124695000},"page":"114858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Detection of HIV-1 matrix protein p17 in sera of viremic and aviremic patients"],"prefix":"10.1016","volume":"324","author":[{"given":"Alberto","family":"Zani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Messali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Uggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Caccuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jviromet.2023.114858_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv062","article-title":"Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17","volume":"73","author":"Basta","year":"2015","journal-title":"Pathog. Dis."},{"issue":"6","key":"10.1016\/j.jviromet.2023.114858_bib2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/ijms21062022","article-title":"Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the HIV-1 matrix protein p17","volume":"21","author":"Bugatti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100934","article-title":"Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants","volume":"297","author":"Bugatti","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.jviromet.2023.114858_bib4","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1073\/pnas.1206605109","article-title":"HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2","volume":"109","author":"Caccuri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jviromet.2023.114858_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/ATVBAHA.113.302478","article-title":"HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1\/endothelin B receptor axis","volume":"34","author":"Caccuri","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jviromet.2023.114858_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/srep38027","article-title":"Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17","volume":"6","author":"Caccuri","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jviromet.2023.114858_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01200-21","article-title":"The HIV-1 matrix protein p17 does cross the blood-brain barrier","volume":"96","author":"Caccuri","year":"2022","journal-title":"J. Virol."},{"issue":"27","key":"10.1016\/j.jviromet.2023.114858_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122050119","article-title":"HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide","volume":"119","author":"Caccuri","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.jviromet.2023.114858_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/QAD.0b013e328354622a","article-title":"The evolving epidemiology of HIV\/AIDS","volume":"26","author":"De Cock","year":"2012","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.jviromet.2023.114858_bib10","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1073\/pnas.142274699","article-title":"HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor","volume":"99","author":"De Francesco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"46","key":"10.1016\/j.jviromet.2023.114858_bib11","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1073\/pnas.1514748112","article-title":"Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis","volume":"112","author":"Dolcetti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jviromet.2023.114858_bib12","first-page":"114","article-title":"HIV disease progression: immune activation, microbes, and a leaky gut","volume":"15","author":"Douek","year":"2007","journal-title":"Top. HIV Med."},{"issue":"1","key":"10.1016\/j.jviromet.2023.114858_bib13","first-page":"54","article-title":"HIV-associated neurocognitive disorders (HAND)","volume":"17","author":"Elbirt","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jviromet.2023.114858_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154061","article-title":"High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients","volume":"237","author":"Feng","year":"2022","journal-title":"Pathol. Res Pract."},{"issue":"10","key":"10.1016\/j.jviromet.2023.114858_bib15","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1073\/pnas.0800370105","article-title":"HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype","volume":"105","author":"Fiorentini","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/649430","article-title":"Immunologic and virologic events in early HIV infection predict subsequent rate of progression","volume":"201","author":"Ganesan","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.jviromet.2023.114858_bib17","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114858_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-63380-4.00003-2","article-title":"\u03b3-Secretase modulators: current status and future directions","volume":"53","author":"Hall","year":"2014","journal-title":"Prog. Med. Chem."},{"issue":"9","key":"10.1016\/j.jviromet.2023.114858_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2013.12.051","article-title":"Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: a phase I safety and immunogenicity study","volume":"32","author":"Iaria","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/cancers13020305","article-title":"Oncogenic effects of HIV-1 proteins, mechanisms behind","volume":"13","author":"Isaguliants","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.jviromet.2023.114858_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/COH.0000000000000227","article-title":"Immune activation and cardiovascular disease in chronic HIV infection","volume":"11","author":"Longenecker","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.jviromet.2023.114858_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1462-5822.2007.01073.x","article-title":"HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1","volume":"10","author":"Marini","year":"2008","journal-title":"Cell Microbiol."},{"issue":"3","key":"10.1016\/j.jviromet.2023.114858_bib24","first-page":"163","article-title":"HIV-1 infection, microenvironment and endothelial cell dysfunction","volume":"39","author":"Mazzuca","year":"2016","journal-title":"New Microbiol."},{"issue":"10","key":"10.1016\/j.jviromet.2023.114858_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/fvl-2022-0065","article-title":"HIV infection and the risk of cancer: tumorigenicity of HIV-1 auxiliary proteins","volume":"17","author":"Mowla","year":"2022","journal-title":"Future Virol."},{"issue":"41","key":"10.1016\/j.jviromet.2023.114858_bib26","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0506857102","article-title":"Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy","volume":"102","author":"Popovic","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/QAI.0000000000000954","article-title":"Do Biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between hiv infected and uninfected people?","volume":"72","author":"So-Armah","year":"2016","journal-title":"J. Acquir Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jviromet.2023.114858_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.591","article-title":"Neurological disorders in HIV: hope despite challenges","volume":"10","author":"Uwishema","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"issue":"2","key":"10.1016\/j.jviromet.2023.114858_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2141.2003.04053.x","article-title":"HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines","volume":"120","author":"Vitale","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.jviromet.2023.114858_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10875-0","article-title":"HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders","volume":"7","author":"Zeinolabediny","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jviromet.2023.114858_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cmdc.201200577","article-title":"Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein","volume":"8","author":"Zentner","year":"2013","journal-title":"ChemMedChem"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:56:24Z","timestamp":1759056984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093423001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S0166093423001830"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114858","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of HIV-1 matrix protein p17 in sera of viremic and aviremic patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114858"}}